histone modification glutathione Simplified overview of histone modifying

Cytokine Growth Factor Rev 13: 4159 [DOI] [PubMed] [Google Scholar] Miller C.T., Lin L., Casper A.M., Lim J., Thomas D.G., Orringer M.B., et al

A comparison of the crystal structure of peptide-free DAP BII with those of peptide (di, hexa, or octa)-bound forms of DAP BII shows that the large cleft between the catalytic and -helical domains is closed upon peptide binding (Fig

doi: 10.1161/CIRCULATIONAHA.109.910687 83

Hence, future therapeutics will be aimed at optimizing the rate of activation and directing it toward maintaining the cellular homeostasis

Clinical and molecular response in core binding factor acute myelogenous leukemia with fludarabine, cytarabine, G-CSF and gemtuzumab ozogamicin, poster presentation